Table 1.
P1-5' AA CATATGACCCCCCTGGGCCCTGCCAGCTCCCTGCCCCAGAGCTTCCTGCTC AAGTG 3' |
P2-5' GCGCTGCGCCATCGCCCTGGATCTTCCTCACTTGCTCTAAGCACTTGAGCA 3' |
P3-5' GGCGCAGCGCTCCAGGAGAAGCTGTGTGCCACCTACAAGCT 3' |
P4-5' CCAGAGAGTGTCCGAGCAGCACCAGCTCCTCGGGGTGGCACAGCTTGTAGG 3' |
P5-5' CACTCTCTGGGCATCCCCTGGGCTCCCCTGAGCAGCTGCCCCAGCCAGGCCCTG CAG 3' |
P6-5' GGTAGAGGAAAAGGCCGCTATGGAGTTGGCTCAAGCAGCCTGCCAGCTGCA GGGCC 3' |
P7-5' TTCCTCTACCAGGGGCTCCTGCAGGCCCTGGAAGGGATCTCCCCCGAGTTGGGT C 3' |
P8-5' TGGTGGCAAAGTCGGCGACGTCCAGCTGCAGTGTGTCCAAGGTGGGACCCAACT C 3' |
P9'-5' TTTGCCACCACCATCTGGCAGCAGATGGAAGAACTGGGAATGGCCCCT GCC CT 3' |
P10-5' AAAGCAGAGGCGAAGGCCGGCATGGCACCCTGGGTGGGCTGCAGGGCAGGGG 3' |
P11-5' CCTCTGCTTTCCAGCGCCGGGCAGGAGGGGTCCTGGTTGCCTCCCATCTGC AGAGCTTCC 3' |
P12-5'AA GGATCCTCAGGGCTGGGCAAGGTGGCGTAGAACGCGGTACGACACCTCCAGGAAGCTCTG 3' |
* Primer sequences for construction of hG-CSF. The G-CSF nucleotide sequence (Accession number NM_000759) of 522 bp, was divided into 12 DNA sequences of approximately 50 bp each, containing 10-bp overlapping regions at their 5'- and 3'-ends for adjacent oligonucleotides. The restriction sites, Nde I and Bam HI, are underlined in primers P1 and P12, respectively.